Presentation

Authors

Session

 

 

3.

(AB29-3) Spatially discordant alternans in cardiac tissue: the role of calcium cycling

Yohannes Shiferaw, PhD, Daisuke Sato, Alan Garfinkel, Zhillin Qu, James N.. Weiss and Alain Karma. university of california, los angeles, Los angeles, CA, Northeastern University, Boston, MA, ucla, Los angeles, CA, ucla, CA

Oral Abstract Sessions
AB29. BASIC/TRANSLATIONAL SCIENCE V: Computer Modeling/Simulation

 

5.

(P1-17/P1-17) Does QT Interval Restitution Predict T-Wave Alternans in high risk patients?

Irfan A. Khan, MD, Ottorino Costantini, MD, Noha Dardir, MD, David S. Rosenbaum, MD and William R. Lewis, MD. MetroHealth Campus, Case Western Reserve University, Cleveland, OH

Poster Sessions
POST01.
POSTER SESSION 1

 

7.

(P6-32/P6-32) Prevalence of T Wave Alternans in the Long QT Syndrome Population: a Study Involving 25 Long QT Syndrome Families

Mustafa H. Hassan, MD and Elizabeth S. Kaufman, MD. Case Western Resreve University MetroHealth Campus, Westlake, OH, Case Western Resreve University MetroHealth Campus, Cleveland, OH

Poster Sessions
POST06.
POSTER SESSION 6

 

 

11.

(P2-25/P2-25) Adrenergic stimulation promotes T-wave Alternans in a TNF-α genetic mouse model of congestive heart failure

Vladimir Shusterman, MD, PhD, Anna Goldberg, BS and Barry London, MD, PhD. University of Pittsburgh, Pittsburgh, PA

Poster Sessions
POST02.
POSTER SESSION 2

 

12.

(AB16-5) T-Wave Alternans Detected From Implantable Cardioverter Defibrillator Electrograms

Offir Paz, MD, Xiaohong Zhou, MD, Tracey Gerez, BS, Jennifer Grannis, BA, Jack Tseng, BS, Eli S. Gang, MD and Charles Swerdlow, MD. Cedars Sinai Medical Center, Los Angeles, CA, Medtronic Inc, Minneapolis, MN

Oral Abstract Sessions
AB16. DEVICES V: ICD Technology: The Dark and Bright Sides of Things

 

16.

T Wave Alternans

Daniel M. Bloomfield, MD

Mini-Course
MC09.
Risk Stratification in Ischemic and Nonischemic Cardiomyopathy

 

17.

Chair

Richard J. Cohen, MD, PhD

Meet the Experts Luncheon
ME01. Why and How to Assess T Wave Alternans

 

18.

(1) Invited Speaker

Thomas Klingenheben, MD

Meet the Experts Luncheon
ME01. Why and How to Assess T Wave Alternans

 

19.

(2) Invited Speaker

Takanori Ikeda, MD

Meet the Experts Luncheon
ME01. Why and How to Assess T Wave Alternans

 

20.

(3) Invited Speaker

Ottorino Costantini, MD

Meet the Experts Luncheon
ME01. Why and How to Assess T Wave Alternans

 

 

 

 

 

21.

(1) Action Potential Alternans and Changes in CA2 Homeostasis

Kenneth R. Laurita, PhD

Core Curriculum
CC09.
Intracellular Calcium and Cardiac Arrhythmia (Joint Session - Heart Rhythm Society and the Cardiac EP Society)

 

23.

(AB27-3) Predictive power of T wave alternans in patients with left ventricular dysfunction and QRS prolongation

Sarah B. Levin, MD, J. Thomas. Bigger, MD, Richard C. Steinman, BA, Michael K. Parides, PhD, Daniel M. Bloomfield, MD, Pearila B. Namerow, PhD, TWA in CHF Investigators. Columbia Presbyterian Medical Center, New York, NY

Oral Abstract Sessions
AB27. NONINVASIVE EVALUATION I: Refinement of Risk Stratification

 

25.

(P2-30/P2-30) Biventricular Pacing Reduces the Positivity of T-Wave Alternans

Daejoon Anh, MD, Scott Vasconcellos, MD, Uma Srivatsa, MD, Nancy McCormick, RN, CNP and Sanjiv M. Narayan, MD, PhD. Henry Ford Hospital, Detroit, MI, UCSD and VA Medical Centers, San Diego, CA

Poster Sessions
POST02.
POSTER SESSION 2

 

26.

(P5-26/P5-26) Indeterminate TWA Tests Are Reduced By Ventricular versus Atrial Pacing

Scott Vasconcellos, MD, Daejoon Anh, MD, Uma Srivatsa, MD, Nancy McCormick, RN, CNP and Sanjiv M. Narayan, MD, PhD. UCSD and VA Medical Centers, San Diego, CA, Henry Ford Hospital, Detroit, MI

Poster Sessions
POST05.
POSTER SESSION 5

 

27.

(P3-27/P3-27) Repeated Assessment of Microvolt Level T-Wave Alternans in Patients With Acute Myocardial Infarction and Reduced LVEF: Results From a Long-Term Follow-up Study

Thomas Klingenheben, MD, Christoph Haenisch, MD, Gerian C. Grönefeld, MD and Stefan H. Hohnloser, MD. J. W. Goethe University, Frankfurt, Germany

Poster Sessions
POST03.
POSTER SESSION 3

 

29.

(P3-26/P3-26) Is T Wave Alternans a Predictor of Reversible Left Ventricular Dysfunction?

Alberto Diaz, MD, Karen Kutoloski, DO, Mary Dettmer, RN, BSN and Ottorino Costantini, MD. MetroHealth Campus, Case Western Reserve University, Cleveland, OH

Poster Sessions
POST03.
POSTER SESSION 3

 

30.

(P2-29/P2-29) Prognostic Value of Microvolt T Wave Alternans In Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis.

Manish Undavia, MD, Vithaya Chaithiraphan, MD, Sonal Jani, MD, Ramesh M. Gowda, MD, Paul Schweitzer, MD and David L. Brown, MD. Beth Israel Medical Center, New York, NY, Stony Brook University School of Medicine, NY

Poster Sessions
POST02.
POSTER SESSION 2

 

 

 

 

 

31.

(AB27-2) Relative Predictive Value of T Wave Alternans and Left Ventricular Ejection Fraction for Death and Sustained Ventricular Arrhythmias in Patients with Left Ventricular Dysfunction

J. Thomas Bigger, MD, Michael K. Parides, PhD, Richard C. Steinman, BA, Pearila B. Namerow, PhD, Daniel M. Bloomfield, MD, for the TWA in CHF Investigators. Columbia University Medical Center, New York, NY

Oral Abstract Sessions
AB27. NONINVASIVE EVALUATION I: Refinement of Risk Stratification

 

32.

(P5-25/P5-25) Increased repolarization alternans following myocardial infarction is related to adverse left ventricular remodeling: Implications for risk assessment & use of defibrillator therapy.

Derek V. Exner, MD, MPH, Katherine Kavanagh, MD, Ryan Mitchell, BSc, Sandeep Aggarwal, MD, Mariko Shibata, BSc, Darlene Ramadan, RN, Henry Duff, MD, REFINE Investigators. University of Calgary, Calgary, AB, Canada

Poster Sessions
POST05.
POSTER SESSION 5

 

35.

(P5-40/P5-40) Gender-Related Differences in Clinical Characteristics of Patients With Congestive Heart Failure. Data From the ALPHA (t wave Alternans in Patients with Heart fAilure) Study Registry

Massimo Tritto, MD, Elisa Favro, MD, Giacinto Pettinati, MD, Enrico Barbieri, MD, Giosuč Mascioli, MD, Valentina Conti, MD, Miriam Revera, MD, Simona Sarzi Braga, MD, Giorgio Bartesaghi, MD, Catherine Klersy, MD, Luciano Sallusti and Jorge A. Salerno-Uriarte, MD. University of Insubria, Clinical Institute Mater Domini, Castellanza (VA), Italy, University of Torino, San G.Battista Hospital, Torino, Italy, F. Ferrari Hospital, Casarano (LE), Italy, Sacro Cuore Hospital, Negrar, Italy, University of Brescia, Spedali Civili Hospital, Brescia, Italy, University of Piemonte Orientale, Maggiore Hospital, Novara, Italy, University of Pavia, IRCCS San Matteo Hospital, Pavia, Italy, IRCCS S.Maugeri Foundation, Scientific Institute, Tradate (VA), Italy, University of Insubria, Circolo Hospital and Macchi Foundation, Varese, Italy, Division of Biometry and Clinical Epidemiology, University of Pavia, IRCCS San Matteo Hospital, Pavia, Italy, Guidant Italia, Milano, Italy

Poster Sessions
POST05.
POSTER SESSION